Summary
Pharmaceuticals in Scandinavia industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2016-20, and forecast to 2025). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Key Highlights
- The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare.
- The Scandinavian pharmaceuticals market had total revenues of $15.2bn in 2020, representing a compound annual growth rate (CAGR) of 2.8% between 2016 and 2020.
- Although an attractive investment market due to high-quality researchers, good infrastructure, and a high innovation rate, Scandinavian markets are increasingly facing the threat of competition from expanding manufacturing capabilities in the Asia-Pacific region.
- The strong emphasis placed on fitness and healthy eating in Scandinavian countries could contribute to a reduced demand for pharmaceutical products, given that such factors are key preventors of illness and disease.
Scope
- Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the pharmaceuticals market in Scandinavia
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in Scandinavia
- Leading company profiles reveal details of key pharmaceuticals market players’ global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the Scandinavia pharmaceuticals market with five year forecasts
Reasons to Buy
- What was the size of the Scandinavia pharmaceuticals market by value in 2020?
- What will be the size of the Scandinavia pharmaceuticals market in 2025?
- What factors are affecting the strength of competition in the Scandinavia pharmaceuticals market?
- How has the market performed over the last five years?
- Who are the top competitors in Scandinavia's pharmaceuticals market?
'
Table of Contents
1 Executive Summary
1.1. Market value
1.2. Market value forecast
1.3. Geography segmentation
1.4. Market share
1.5. Market rivalry
1.6. Competitive Landscape
2 Market Overview
2.1. Market definition
2.2. Market analysis
3 Market Data
3.1. Market value
4 Market Segmentation
4.1. Geography segmentation
5 Market Outlook
5.1. Market value forecast
6 Five Forces Analysis
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 Competitive Landscape
7.1. Market share
7.2. Who are the leading players?
7.3. What strategies do leading players follow?
7.4. How have leading players responded to the COVID-19 pandemic?
7.5. Are there any threats towards leading players?
8 Company Profiles
8.1. Novartis AG
8.2. Sanofi SA
8.3. F. Hoffmann-La Roche Ltd
8.4. Pfizer Inc.
9 Macroeconomic Indicators
9.1. Country data
10 Appendix
10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine
List of Tables
Table 1: Scandinavia pharmaceuticals market value: $ billion, 2016-20
Table 2: Scandinavia pharmaceuticals market geography segmentation: $ billion, 2020
Table 3: Scandinavia pharmaceuticals market value forecast: $ billion, 2020-25
Table 4: Scandinavia pharmaceuticals market share: % share, by value, 2020
Table 5: Novartis AG: key facts
Table 6: Novartis AG: Annual Financial Ratios
Table 7: Novartis AG: Key Employees
Table 8: Novartis AG: Key Employees Continued
Table 9: Sanofi SA: key facts
Table 10: Sanofi SA: Annual Financial Ratios
Table 11: Sanofi SA: Key Employees
Table 12: Sanofi SA: Key Employees Continued
Table 13: F. Hoffmann-La Roche Ltd: key facts
Table 14: F. Hoffmann-La Roche Ltd: Annual Financial Ratios
Table 15: F. Hoffmann-La Roche Ltd: Key Employees
Table 16: Pfizer Inc.: key facts
Table 17: Pfizer Inc.: Annual Financial Ratios
Table 18: Pfizer Inc.: Key Employees
Table 19: Pfizer Inc.: Key Employees Continued
Table 20: Scandinavia exchange rate, 2016-20
List of Figures
Figure 1: Scandinavia pharmaceuticals market value: $ billion, 2016-20
Figure 2: Scandinavia pharmaceuticals market geography segmentation: % share, by value, 2020
Figure 3: Scandinavia pharmaceuticals market value forecast: $ billion, 2020-25
Figure 4: Forces driving competition in the pharmaceuticals market in Scandinavia, 2020
Figure 5: Drivers of buyer power in the pharmaceuticals market in Scandinavia, 2020
Figure 6: Drivers of supplier power in the pharmaceuticals market in Scandinavia, 2020
Figure 7: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Scandinavia, 2020
Figure 8: Factors influencing the threat of substitutes in the pharmaceuticals market in Scandinavia, 2020
Figure 9: Drivers of degree of rivalry in the pharmaceuticals market in Scandinavia, 2020
Figure 10: Scandinavia pharmaceuticals market share: % share, by value, 2020
